Member Info for Scoutt

For a cheap quick reliable test, if this is it ,it will clean up until a vaccine is found, but the affirmer technology is going to be the holy grail for future pandemics. With the world population increasing exponentially and pandemics proportional to human density testing and 3D virus modelling are the only way to prevent further pandemics. Synairgen seem to effectively cover the latter aspect. Once news sinks in this could make Ncyt look pedestrian.

Will also top up at 6.75 if it gets that low will even breach my 10% of portfolio rule as this is a once in a life time bet, lose 50% gain 200% to the blue, blue sky. Until news next week it’s all hearsay.

Don’t know if you’re aware but Haf Arian in Welsh means Summer gold(money) here’s wishing for a golden summer

At last news, maybe a rerating, surely private equity must be circling thinking it’s a steal, flog off Fed keep the cash to fund the other companies it’s a win win. Anyway whoever it is will have to prize the shares out of my white knuckled dead fingers fo r less than 60p. Gg

Expect stable price or slight drift until news, double blind trial means until all results are validated no conclusions can be drawn. Early May is my prediction as fast tracking means just that, the normal peer referral and review will be bypassed as Government despair are for the good news, Astra Z will want to band wagon and once the price starts rising it’s going to be nigh on impossible to get on board. Anyway await news and the lift off.

Great rise, anyone who after my post looked at Prim is sitting on a very hefty 50% profit although in my opinion has further to go, odd then that Starvest is lagging as they are even more geared to ggp price, funny old thing the market.

Time to take stock of the share price as it looks like it’s being pushed to far too fast. If it goes above 8p I am looking for the inevitable retrace and selling hoping to get back in later in week, I will reinvest proceeds in Starvest and Primerous both proxies for ggp and better value at moment provided Prim doesn’t rocket on news today.

Sorry got on here to discuss synairgen obviously Ncyt have renamed themselves, anyway Ncyt your game is up with AVs test, which is cheap, can be done anywhere with a piece of paper and some spit. Maybe one day this site may actually discuss a cure for corvid 19 as I believe Synairgan are about to inform us.

Very impressive interview, packed with potential but not overhyped. confirmed my belief that a rapid detection at a cost effective price is the way forward at least until a cure is found for Corvid 19. I was also impressed with Avacta’s ability to develop their propriety solutions for other virus’s and this is where the real value lies, I imagine Avacta will be snapped up eventually by a large pharma providing the price doesn’t rise exponentially. I would have thought that a lot of the mega cap Parma’s are running a slide rule but cannot bid at the moment as it would be commercial suicidal to be seen to be profiteering at the expense of the crisis. Can see this going one way only particularly when news emerges.

Probably the most undervalued aim share, tuck a few more before t he herd get wind for as sure as eggs as ggp rises so do Starvest perhaps with a slight lag. Gg

You have to wonder why everything has gone so suspiciously quiet here. Crystal must be doing everything they can to moniterise their investment, even if it’s not for fair value. I am expecting news soon as not even this useless board could not have some irons in the fire. I will be happy to write this off for 50 p despite the terrific companies in the portfolio. You have to think what would have happened if Draper Esprit had run the show, we would probably been over £12 by now.

Odd you would think the corona virus had never happened, blue sky’s and all, not that every government in the world has gotten hold of the borrowing tiger and sxxx scarred of letting go. It’s the kids I feel sorry about they will be paying for this monumental cxxxup for the next 25 years. Gold WILL be the next reserve currency, my guess is $2500 by July, then we’ll really see what ggp is worth.

Sustained rise augurs well, would not like to day trade this at the moment and be out over week end, Starvest and Primerous up by identical amounts. Seems orchestrated, those MM’s finally getting their act together.

When I first speculated in ggp it was 1.2p and it’s liquidity was “crap”, my take on primerous and Starvest is that having such liquid holdings in ggp their “illiquidness” Is an anomaly, and as such can be exploited profitably. So if you really do want ggp at a discount I suggest you check out both Starvest and Primerous. Apologies for the invented words seems to be acceptable nowadays.

Buys now seem to be influencing price, does not appear to have a share overhang left. Not tempted to chase this higher as A better way to play price increase is via Starvest or primerous. Both have significant holdings I ggp, of 85 million and 35 million respectively and both companies are trading at less than the value of their ggp holdings alone , meaning the other holdings are less than free. I like both but primerous have some seriously good other investments and the management is sound.Starvest seem good but the spread is painful at times. Anyway a rising tide floats all vessels. Do your own research I you are interested in the companies listed above. GLH

Seems the best of the bunch re. testing, time and reliability of the essence we apparently have both in spades. When this takes off on Mondays results will make Ncyt look pedestrian. Anyway something to look forward too besides a side bet with Synairgen.

That’s much better, if it holds . Will rise to align itself to 70% NAV or about 11p. Awaiting news late April of Newcrest's drilling of Haverion, should be interesting and very profitable. Hold for the rising cost of goldin very uncertain times.

Checked portfolio and realised still have £500 worth of these originally put in £1500 based on massive reduction to NAV about 85%, nice to see the board are working overtime to reduce the NAV to zero. Crony capitalism at its best , awaiting the board to run out of money and then perhaps a fund raise. Cannot see where this is going but not worth cashing in so in it TIL the bitter bitter end.

Little point speculating on news coming in an hour or so, good time to be speculating on share price as there is only the possibility of good news or no new news. Just added as this seems to be following price profile as Ncyt, but unlike them this is not a one trick pony, this treatment has major implications in treatment of many lung function diseases.

Seems positive, could be leaky news. Not chasing this higher as a better play is Starvest who got 85million ggp shares plus a lot more, and is capitalised at less than 60% of its ggp holding. Spread is painful at moment, about 10%, but should reduce as stock becomes more liquid. If ggp does take off as we suspect, you should get the full rise plus 40% as a special dividend. Anyway do your own research.